Diabetic patients may be particularly vulnerable to developing mental health disorders because diabetes is considered one of the most psychologically and behaviorally demanding chronic medical conditions.
There are many reasons for the occurrence of cognitive impairment in patients during hospitalization, and this impairment can have a long-term impact post discharge.
A pattern of impulsiveness and mood instability characterizes this psychological condition.
Patients should be monitored for increased intracranial pressure and seizure occurrence.
Posttraumatic stress disorder is a mental health condition that is triggered by experiencing or witnessing a traumatic event involving the possibility of serious injury or death.
Differential diagnosis of a panic attack is critical to providing appropriate drug therapy.
QT-interval prolongation is estimated to occur in up to 10% of patients taking antiarrhythmic drugs with QT-prolonging potential.
New therapies prevent and reduce the duration and severity of swelling episodes.
Eating disorders often presents differently in men than in women, and the incidence in males is likely higher than reported.
Providing medication therapy management (MTM) for patients with diabetes presents many challenges.
This article reviews four new drugs (secukinumab, dulaglutide, naloxegol, ledipasvir-sofosbuvir) approved by the FDA in the past year.
Despite the success of standard regimens, antiretroviral therapy is complicated by potential drug-drug interactions, patient nonadherence, and adverse effects.
This article discusses four new molecular entities (edoxaban, ceftazidime-avibactam, atazanavir-cobicistat, palbociclib) recently approved by the FDA.
In most patients, sarcoidosis improves on its own, but in about one-third of cases, it ultimately becomes a chronic condition that negatively affects the organs and overall quality of life.
Historically, the U.S. healthcare system has been disjointed and rigid, with millions of Americans either uninsured or underinsured.
Long-term use of proton pump inhibitors may cause an increased risk of falls and fractures.
Many options are available for patients experiencing symptomatic or bothersome manifestations.
Polycystic ovarian syndrome, which is a complex disease, is the most common endocrine disorder affecting females of reproductive age.
Hormone replacement therapy is a key element of managing the symptoms experienced by menopausal women.
The FDA recently approved the first agent for treatment of hypoactive sexual desire disorder.
For more articles, please check our archives.